ATTR Cardiac Amyloidosis in a Selected Population
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorHelse Møre og Romsdal HF
About this trial
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
Eligibility criteria
Qualifiers
Male > 50 years
Female > 60 years
operated CTS at Ålesund Hospital
Disqualifiers
not consented
do not speak Norwegian
secondary cause of CTS as traumatic or rheumatic
cannot be followed > 5 years due to other medical conditions
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Ålesund Hospital6026, ÅlesundMøre og Romsdal, Norway
Sponsors and collaborators
Helse Møre og Romsdal HF
Lead sponsor
Source ClinicalTrials.gov